174 related articles for article (PubMed ID: 26213156)
1. The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion.
Akamine Y; Miura M; Komori H; Tamai I; Ieiri I; Yasui-Furukori N; Uno T
Drug Metab Pharmacokinet; 2015 Oct; 30(5):352-7. PubMed ID: 26213156
[TBL] [Abstract][Full Text] [Related]
2. Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers.
Akamine Y; Miura M; Komori H; Saito S; Kusuhara H; Tamai I; Ieiri I; Uno T; Yasui-Furukori N
Eur J Clin Pharmacol; 2014 Sep; 70(9):1087-95. PubMed ID: 24903351
[TBL] [Abstract][Full Text] [Related]
3. A modified grapefruit juice eliminates two compound classes as major mediators of the grapefruit juice-fexofenadine interaction: an in vitro-in vivo "connect".
Won CS; Lan T; Vandermolen KM; Dawson PA; Oberlies NH; Widmer WW; Scarlett YV; Paine MF
J Clin Pharmacol; 2013 Sep; 53(9):982-90. PubMed ID: 23878024
[TBL] [Abstract][Full Text] [Related]
4. Long-lasting inhibitory effect of apple and orange juices, but not grapefruit juice, on OATP2B1-mediated drug absorption.
Shirasaka Y; Shichiri M; Murata Y; Mori T; Nakanishi T; Tamai I
Drug Metab Dispos; 2013 Mar; 41(3):615-21. PubMed ID: 23264447
[TBL] [Abstract][Full Text] [Related]
5. An update on the clinical pharmacokinetics of fexofenadine enantiomers.
Akamine Y; Miura M
Expert Opin Drug Metab Toxicol; 2018 Apr; 14(4):429-434. PubMed ID: 29635947
[TBL] [Abstract][Full Text] [Related]
6. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
Dresser GK; Kim RB; Bailey DG
Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611
[TBL] [Abstract][Full Text] [Related]
7. Substrate- and dose-dependent drug interactions with grapefruit juice caused by multiple binding sites on OATP2B1.
Shirasaka Y; Mori T; Murata Y; Nakanishi T; Tamai I
Pharm Res; 2014 Aug; 31(8):2035-43. PubMed ID: 24549825
[TBL] [Abstract][Full Text] [Related]
8. Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1.
Medwid S; Li MMJ; Knauer MJ; Lin K; Mansell SE; Schmerk CL; Zhu C; Griffin KE; Yousif MD; Dresser GK; Schwarz UI; Kim RB; Tirona RG
Drug Metab Dispos; 2019 Aug; 47(8):832-842. PubMed ID: 31123035
[TBL] [Abstract][Full Text] [Related]
9. Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers.
Akamine Y; Miura M; Yasui-Furukori N; Ieiri I; Uno T
J Clin Pharm Ther; 2015 Feb; 40(1):98-103. PubMed ID: 25263393
[TBL] [Abstract][Full Text] [Related]
10. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB
Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
[TBL] [Abstract][Full Text] [Related]
11. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice.
Bailey DG; Dresser GK; Leake BF; Kim RB
Clin Pharmacol Ther; 2007 Apr; 81(4):495-502. PubMed ID: 17301733
[TBL] [Abstract][Full Text] [Related]
12. Fruit juice inhibition of uptake transport: a new type of food-drug interaction.
Bailey DG
Br J Clin Pharmacol; 2010 Nov; 70(5):645-55. PubMed ID: 21039758
[TBL] [Abstract][Full Text] [Related]
13. Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions.
Shirasaka Y; Shichiri M; Mori T; Nakanishi T; Tamai I
J Pharm Sci; 2013 Sep; 102(9):3418-26. PubMed ID: 23794501
[TBL] [Abstract][Full Text] [Related]
14. The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans.
Imanaga J; Kotegawa T; Imai H; Tsutsumi K; Yoshizato T; Ohyama T; Shirasaka Y; Tamai I; Tateishi T; Ohashi K
Pharmacogenet Genomics; 2011 Feb; 21(2):84-93. PubMed ID: 21280267
[TBL] [Abstract][Full Text] [Related]
15. [Determinants of the stereoselective pharmacokinetics of fexofenadine].
Akamine Y
Yakugaku Zasshi; 2015; 135(3):473-81. PubMed ID: 25759055
[TBL] [Abstract][Full Text] [Related]
16. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
[TBL] [Abstract][Full Text] [Related]
17. Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions.
Shirasaka Y; Shichiri M; Mori T; Nakanishi T; Tamai I
J Pharm Sci; 2013 Jan; 102(1):280-8. PubMed ID: 23132664
[TBL] [Abstract][Full Text] [Related]
18. Effect of grapefruit juice on the disposition of manidipine enantiomers in healthy subjects.
Uno T; Ohkubo T; Motomura S; Sugawara K
Br J Clin Pharmacol; 2006 May; 61(5):533-7. PubMed ID: 16669846
[TBL] [Abstract][Full Text] [Related]
19. Effect of fruit juices on the oral bioavailability of fexofenadine in rats.
Kamath AV; Yao M; Zhang Y; Chong S
J Pharm Sci; 2005 Feb; 94(2):233-9. PubMed ID: 15570603
[TBL] [Abstract][Full Text] [Related]
20. Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects.
Rebello S; Zhao S; Hariry S; Dahlke M; Alexander N; Vapurcuyan A; Hanna I; Jarugula V
Eur J Clin Pharmacol; 2012 May; 68(5):697-708. PubMed ID: 22124880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
